We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Explainer: What Is PhRMA?
CSL CEO Paul Perreault recently joined the board of the Pharmaceutical Research and Manufacturers of America.
Industry Partnership Fuels Research, Advocacy
PhRMA membership expands CSL Behring’s opportunity for cooperation between industry leaders.
CSL CEO at Utah Life Sciences Summit
At biotech event, Paul Perreault will talk about the company’s COVID-19 response – including a potential treatment now in a c…
Watch Online: CSL CEO at a White House Roundtable
Perreault made the case for a plasma-based hyperimmune to treat COVID-19.
CEO Paul Perreault at White House Roundtable
Perreault, representing the plasma industry, said an antibody treatment depends on additional donations from recovered patien…
CSL CEO: Don't Rush the COVID-19 Vaccine
Joining scientists and medical experts, Perreault urges rigor, precision and the necessary time to ensure vaccine safety.
Dealing With Challenges Head-On
CSL Limited CEO Paul Perreault offers a message of encouragement during the COVID-19 pandemic.
Podcast With CSL CEO Paul Perreault
“I want to make sure that we’re all supporting each other, practicing self-care, and if anybody reaches out, we’re there to t…
‘Our Promises Are Never Rare’
CSL’s CEO reflects on the importance of recognizing Rare Disease Day.
What Is the J.P Morgan Healthcare Conference?
This mega-meeting in San Francisco focuses on biotech deals and investors, but rare disease advocates are also seizing the mo…
Four Academic Partnerships We're Excited About
Around the world, CSL is building creative partnerships with universities and research institutions.
CSL Limited Marks 25 Years on the ASX
Leaders ring the opening bell in Sydney and reflect on the company’s transformation into a global biotechnology business.
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
.jpeg?h=900&w=1600&cropregion=0,0,1600,900&hash=58F4D8F732DF34A6F68F6ABEEFF74F82585879C1)
